MHC Class Ia Fusion Dimers for Treatment of Cancer
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,807,676 | MHC Class Ia Open Conformers In force · High confidence | Universität Basel | In force | High confidence | ||
| US 11,279,747 | MHC Class Ia Fusion Dimers for Treatment of Cancer In force · High confidence | Universitat Basel | In force | High confidence |
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Universitat Basel.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.